Sanjeev Kr Chauhan is a visionary founder of Probgen, a pioneering company in advanced molecular diagnostics. With a strong foundation in clinical science and extensive experience in diagnostic research, Chauhan has been instrumental in creating innovative healthcare solutions that enable accurate and early disease detection.

Under his leadership, Probgen has become a trusted provider of high-quality diagnostic assays, including qPCR, dPCR, and multiplex RT-PCR kits used in infectious diseases, oncology, respiratory health, and genetic testing. He has consistently driven the company toward excellence by emphasizing quality, innovation, and research, while maintaining compliance with global standards such as ISO13485.

Chauhan’s mission is fueled by a commitment to improving patient outcomes and making cutting-edge diagnostics more accessible. His passion for innovation and his compassionate approach have inspired his team to strive for smarter, faster, and more reliable diagnostic tools.

Through Probgen, Sanjeev Kr Chauhan continues to bridge the gap between laboratory science and real-world clinical care—leaving a meaningful impact on healthcare with integrity, purpose, and forward-thinking leadership.